MICHELLE HOREV: Open Payments
NPI 1831868421 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 74 payments from 12 companies in 2025. Trend: 2023 $801 · 2024 $1,535 · 2025 $2,189
Food & beverage: $2,001Education: $188
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $427 |
| Actelion Pharmaceuticals US, Inc. | 9 | $421 |
| Merck Sharp & Dohme LLC | 9 | $321 |
| Novo Nordisk Inc | 12 | $229 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $182 |
| Alnylam Pharmaceuticals Inc. | 3 | $159 |
| PFIZER INC. | 8 | $155 |
| BridgeBio Pharma, Inc. | 5 | $142 |
| United Therapeutics Corporation | 3 | $78 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: WINREVAIR, UPTRAVI, OPSUMIT, Kerendia, AMVUTTRA, LOKELMA, VYNDAQEL, Attruby.
Industry payments across FL — which companies pay providers there.
